e-learning
resources
Virtual 2020
Pre-Congress Content
Monitoring of inflammation in remodelling
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.
G. Tavernier (Manchester (Greater Manchester), United Kingdom), P. Aspin (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom), D. Allen (Manchester (Greater Manchester), United Kingdom), R. Niven (Manchester (Greater Manchester), United Kingdom)
Source:
Virtual Congress 2020 – Monitoring of inflammation in remodelling
Session:
Monitoring of inflammation in remodelling
Session type:
E-poster session
Number:
3315
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
G. Tavernier (Manchester (Greater Manchester), United Kingdom), P. Aspin (Manchester (Greater Manchester), United Kingdom), S. Fowler (Manchester (Greater Manchester), United Kingdom), D. Allen (Manchester (Greater Manchester), United Kingdom), R. Niven (Manchester (Greater Manchester), United Kingdom). How different operators performing sputum eosinophil differential cell counts may affect clinical decisions for severe asthma patients.. 3315
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
The use of sputum differential cell counts and soluble phase measurements to assess airway inflammation in children with asthma exacerbation
Source: Eur Respir J 2002; 20: Suppl. 38, 142s
Year: 2002
Determining asthma treatment by monitoring sputum cell counts: effect on exacerbations
Source: Eur Respir J 2006; 27: 483-494
Year: 2006
Accuracy of blood eosinophil count in predicting sputum eosinophils in children with problematic severe asthma (PSA)
Source: Virtual Congress 2020 – Novel mechanisms and management of paediatric asthma
Year: 2020
The need of analysing induced sputum absolute cell counts in addition to cell percentages in COPD
Source: Eur Respir J 2004; 24: Suppl. 48, 306s
Year: 2004
BAL eosinophil counts and specific clinical phenotypes of asthmatic and/or atopic children
Source: Annual Congress 2011 - Flexible bronchoscopy in the diagnosis of paediatric lung diseases
Year: 2011
Automated cell differential count in sputum is feasible and comparable to manual cell count in identifying eosinophilia
Source: International Congress 2019 – Research and innovation in airway diseases
Year: 2019
A study on the relevance of eosinophil counts in induced sputum and FENO and lung functions in asthmatics
Source: Annual Congress 2010 - Induced sputum in relation: a fresh look on phenotyping and monitoring
Year: 2010
Comparative characteristics of induced sputum and brush-biopsy cell counts in COPD exacerbation
Source: Eur Respir J 2005; 26: Suppl. 49, 299s
Year: 2005
The impact of high eosinophil count on hospitalizations in COPD patients
Source: International Congress 2018 – Biomarkers of COPD
Year: 2018
An investigation of apoptotic eosinophil numbers in induced sputum: is there an association with asthma severity?
Source: Eur Respir J 2001; 18: Suppl. 33, 247s
Year: 2001
Cost-effectiveness comparison of three methods for differential cell count in induced sputum
Source: Eur Respir J 2002; 20: Suppl. 38, 274s
Year: 2002
Functional, clinical evolution and cellular inflammatory pattern in induced sputum in patients with difficult-to-control asthma
Source: Annual Congress 2011 - Update on monitoring airway diseases
Year: 2011
The regulation of apoptosis in the induced sputum cells of patients with bronchial asthma (BA) using different therapeutic programms
Source: Eur Respir J 2003; 22: Suppl. 45, 79s
Year: 2003
Does the infection influence on induced sputum cell count at smokers and nonsmokers with COPD exacerbation?
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
Budesoinde/formoterol: does eosinophil count cause different outcomes?
Source: International Congress 2019 – Asthma: outcomes of clinical trials and cohorts
Year: 2019
Change of biochemical parameters of sputum in patients with different types of COPD exaserbation
Source: Annual Congress 2009 - Exacerbations of COPD and bronchiectasis: aetiology and treatment
Year: 2009
The effect of time elapsed since expectoration on sputum eosinophil differential cell counts
Source: International Congress 2019 – Quality, performance and interpretation of lung function testing
Year: 2019
Asthma treatment based on sputum cell counts or usual clinical outcomes: the LOMA study
Source: Eur Respir J 2003; 22: Suppl. 45, 35s
Year: 2003
The usefulness of blood eosinophil count and FeNO to predict sputum eosinophilia in the diagnosis of severe eosinophilic asthma
Source: International Congress 2019 – Eosinophils and FeNO in airway diseases
Year: 2019
Clinical significance of blood neutrophil differential count in patients with COPD
Source: International Congress 2017 – Biomarker-based asthma control
Year: 2017
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept